NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/07/2026
Back to search
Official data from USPTO
GENRIX BIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
07/07/2026
Trademark type
Combined
Nice classes
5
Filing date
05/01/2024
Registration date
07/07/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/07/2026
Last transaction
07/07/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/20/2015
First use in commerce
10/20/2015
Drawing code
5
Owner type
99
Owner location
Chongqing, CN
Examiner
SHEN, DANIEL HOWE
Law office
O10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "GENRIX BIO" where the letter "X" is made up of microorganisms.
Holders and representatives
Holders
CHONGQING GENRIX BIOPHARMACEUTICAL CO., LTD.
Representatives
Alex Patel Patel IP, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Cultures of microorganisms for medical or veterinary use; biological preparations for medical purposes for the treatment of canceroncological diseasescardiovascular and cerebrovascular diseasesrespiratory diseasesgenitourinary diseasesneurological diseasesimmune system related diseasesgastrointestinal diseasesmusculoskeletal diseases and endocrine metabolism-related diseases; medicines for human purposesmedicines for the treatment of viral and infectious diseasesfor the treatment of cancer; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; biological preparations for medical purposes for the prevention and treatment of infectious diseases
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/07/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/12/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/12/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/21/2026
IUAF
USE AMENDMENT FILED
11/21/2025
EISU
TEAS STATEMENT OF USE RECEIVED
11/21/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/24/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/29/2025
PUBO
PUBLISHED FOR OPPOSITION
04/29/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/23/2025
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
03/13/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/08/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/05/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/04/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/04/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/10/2024
GNRT
NON-FINAL ACTION E-MAILED
12/10/2024
CNRT
NON-FINAL ACTION WRITTEN
12/10/2024
DOCK
ASSIGNED TO EXAMINER
11/15/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/28/2024
NWAP
NEW APPLICATION ENTERED
05/01/2024
Continuous trademark protection
Get notified about every new filing that threatens GENRIX BIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.